IN VITRO BIOLOGICAL ACTIVITY ASSESSMENT OF RHEPO PHARMACEUTICAL FORMULATIONS FOR BATCH RELEASE

Journal Title: European Journal of Biomedical and Pharmaceutical Sciences - Year 2017, Vol 4, Issue 2

Abstract

Background: Recombinant human erythropoietin (rhEPO) is the pharmaceutical form of erythropoietin (EPO), used for the treatment of chronic kidney disease and cancer-associated anemia, act as a growth proliferation factor for cells having EPO- receptor on their surfaces such as blood progenitors, non-hematopoietic cells and some types of tumor cells. Methodology: This study is objectively planned for in vitro biological assessment of rhEPO activity as a routine quality control testing, instead of in vivo animal testing. Malignant cell lines such as MCF-7, HepG2, HELA and PC3 were subjected as expermental cells in this study. Growth rate response for rhEPO treatment was estimated by MTT- based bioassay then was confirmed by hemocytometer and microscopical observation. Results: Statistical records reflected that rhEPO at concentration of 0.78 IU/ml to 25 IU/ml causes cell proliferation expontionally at r >0.9. Using single factor ANOVA (T-test), there is a significant cell proliferation at p <0.005 comparing with non-treated cells. Conclusion: Cell proliferation corresponding to rhEPO can be used as a new approach for quality control testing of rhEPO pharmaceutical products.

Authors and Affiliations

Asmaa O. Sana-Eldine

Keywords

Related Articles

NEUROLOGICAL COMPLICATIONS: CHANCES OF SURVIVAL IN CEREBRAL MALARIA

Cerebral malaria is one of the most common non-traumatic encephalopathy in the world. The pathogenesis and neurological complications are often leads to multisystem dysfunction. The clinical presentation differs between...

DEMOGRAPHIC AND PHENOTYPIC CHARACTERIZATION OF DRUG RESISTANT MYCOBACTERIUM TUBERCULOSIS ISOLATED FROM PATIENTS RESIDENT IN RIVERS STATE, NIGERIA

Tuberculosis (TB) remains a leading public health problem worldwide. In Nigeria the burden of TB is high however only a few cases have been reported especially in Rivers State. The aim of this study is to phenotypically...

CHEMICAL COMPOSITION OF THE ESSENTIAL OILS DISTILLED FROM TUBER OF RUMPUT TEKI (CYPERUS ROTUNDUS LINN.) GROWING IN TANGGAMUS, LAMPUNG, INDONESIA

In order to investigate chemical aspects of the Cyperaceae plant family in Lampung Province, Indonesia, this study is aimed to find out chemical composition of the distilled essential oils from rhizomes of rumput teki (C...

EVALUATING FAMILY HISTORY QUESTIONNAIRE VERSUS FAMILY PEDIGREE INTERVIEW FOR GENETIC DISORDERS IN PRIMARY HEALTH CARE, QASSIM REGION, SAUDI ARABIA

Introduction: The use of family history as screening tool (pedigree or questionnaire) has been shown to increase the likelihood of detecting a patient at high risk of developing an inherited medical condition by 20% comp...

CLINICAL OUTCOMES OF POSTERIOR FOSSA TUMOR SURGERY WITHOUT PREOPERATIVE VENTRICULAR-PERITONEAL SHUNT

The aim of the study was to assess the clinical outcome of surgically treated patients with posterior fossa tumor with hydrocephalus with symptoms and signs of raised intracranial pressure without pre-operative ventricul...

Download PDF file
  • EP ID EP628049
  • DOI -
  • Views 169
  • Downloads 0

How To Cite

Asmaa O. Sana-Eldine (2017). IN VITRO BIOLOGICAL ACTIVITY ASSESSMENT OF RHEPO PHARMACEUTICAL FORMULATIONS FOR BATCH RELEASE. European Journal of Biomedical and Pharmaceutical Sciences, 4(2), 1-5. https://europub.co.uk./articles/-A-628049